SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy

EZROVÁ, Z., NAHÁCKA, Z., ŠTURSA, J., WERNER, L., VLČÁK, E., KRÁLOVÁ VIZIOVÁ, P., BERRIDGE, M.V., SEDLÁČEK, R., ZOBALOVÁ, R., ROHLENA, J., BOUKALOVÁ, Š., NEUŽIL, J. SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy. Oncogene. 2021, 40(14), 2539-2552. ISSN 0950-9232. E-ISSN 1476-5594. Dostupné z: doi: 10.1038/s41388-021-01726-4.